DSTU2
This page is part of the FHIR Specification (v1.0.2: DSTU 2). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions 
FHIR Value set/code system definition for HL7 v2 table 0292 ( Vaccines Administered (code = CVX) (parenteral, un)
<ValueSet xmlns="http://hl7.org/fhir"> <id value="v2-0292"/> <meta> <profile value="http://hl7.org/fhir/StructureDefinition/valueset-shareable-definition"/> </meta> <text> <status value="additional"/> <div xmlns="http://www.w3.org/1999/xhtml"> <p>Vaccines Administered (code = CVX) (parenteral, un</p> <table class="grid"> <tr> <td> <b>Code</b> </td> <td> <b>Description</b> </td> <td> <b>Nederlands (Dutch)</b> </td> <td> <b>Comment</b> </td> <td> <b>Version</b> </td> </tr> <tr> <td>01 <a name="01"> </a> </td> <td>DTP</td> <td>DKT - difterie-kinkhoest-tetanus</td> <td>diphtheria, tetanus toxoids and pertussis vaccine</td> <td>added v2.3</td> </tr> <tr> <td>02 <a name="02"> </a> </td> <td>OPV</td> <td>OPV</td> <td>poliovirus vaccine, live, oral</td> <td>added v2.3</td> </tr> <tr> <td>03 <a name="03"> </a> </td> <td>MMR</td> <td>BMR - mazelen, bof, rodehond</td> <td>measles, mumps and rubella virus vaccine</td> <td>added v2.3</td> </tr> <tr> <td>04 <a name="04"> </a> </td> <td>M/R</td> <td>M/R</td> <td>measles and rubella virus vaccine</td> <td>added v2.3</td> </tr> <tr> <td>05 <a name="05"> </a> </td> <td>measles</td> <td>mazelen</td> <td>measles virus vaccine</td> <td>added v2.3</td> </tr> <tr> <td>06 <a name="06"> </a> </td> <td>rubella</td> <td>rodehond</td> <td>rubella virus vaccine</td> <td>added v2.3</td> </tr> <tr> <td>07 <a name="07"> </a> </td> <td>mumps</td> <td>bof</td> <td>mumps virus vaccine</td> <td>added v2.3</td> </tr> <tr> <td>08 <a name="08"> </a> </td> <td>Hep B, adolescent or pediatric</td> <td>Hep B, adolescent of pediatrie</td> <td>hepatitis B vaccine, pediatric or pediatric/adolescent dosage</td> <td>added v2.3</td> </tr> <tr> <td>09 <a name="09"> </a> </td> <td>Td (adult)</td> <td>DT - difterie en tetanus (volwassene)</td> <td>tetanus and diphtheria toxoids, adsorbed for adult use</td> <td>added v2.3</td> </tr> <tr> <td>10 <a name="10"> </a> </td> <td>IPV</td> <td>IPV</td> <td>poliovirus vaccine, inactivated</td> <td>added v2.3</td> </tr> <tr> <td>100 <a name="100"> </a> </td> <td>pneumococcal conjugate</td> <td>pneumokokken conjugaat</td> <td>pneumococcal conjugate vaccine, polyvalent</td> <td>added v2.4</td> </tr> <tr> <td>101 <a name="101"> </a> </td> <td>typhoid, ViCPs</td> <td>tyfus, ViCPs</td> <td>typhoid Vi capsular polysaccharide vaccine</td> <td>added v2.4</td> </tr> <tr> <td>102 <a name="102"> </a> </td> <td>DTP-Hib-Hep B</td> <td>DKT-Hib-Hep B</td> <td>DTP- Haemophilus influenzae type b conjugate and hepatitis b vaccine</td> <td>added v2.5</td> </tr> <tr> <td>103 <a name="103"> </a> </td> <td>meningococcal C conjugate</td> <td>meningokokken C conjugaat</td> <td>meningococcal C conjugate vaccine</td> <td>added v2.5</td> </tr> <tr> <td>104 <a name="104"> </a> </td> <td>Hep A-Hep B</td> <td>Hep A-Hep B</td> <td>hepatitis A and hepatitis B vaccine</td> <td>added v2.5</td> </tr> <tr> <td>105 <a name="105"> </a> </td> <td>vaccinia (smallpox) diluted</td> <td>vaccinia (pokken) verzwakt</td> <td>vaccinia (smallpox) vaccine, diluted</td> <td>added v2.5</td> </tr> <tr> <td>106 <a name="106"> </a> </td> <td>DTaP, 5 pertussis antigens6</td> <td>DaKT, 5 kinkhoest antigenen6</td> <td>diphtheria, tetanus toxoids and acellular pertussis vaccine, 5 pertussis antigens</td> <td>added v2.5</td> </tr> <tr> <td>107 <a name="107"> </a> </td> <td>DTaP, NOS</td> <td>DaKT, niet anders gespecificeerd</td> <td>diphtheria, tetanus toxoids and acellular pertussis vaccine, NOS</td> <td>added v2.5</td> </tr> <tr> <td>108 <a name="108"> </a> </td> <td>meningococcal, NOS</td> <td>meningokokken, niet anders gespecificeerd</td> <td>meningococcal vaccine, NOS</td> <td>added v2.5</td> </tr> <tr> <td>109 <a name="109"> </a> </td> <td>pneumococcal, NOS</td> <td>pneumokokken, niet anders gespecificeerd</td> <td>pneumococcal vaccine, NOS</td> <td>added v2.5</td> </tr> <tr> <td>11 <a name="11"> </a> </td> <td>pertussis</td> <td>kinkhoest</td> <td>pertussis vaccine</td> <td>added v2.3</td> </tr> <tr> <td>110 <a name="110"> </a> </td> <td>DTaP-Hep B-IPV</td> <td>DaKT-Hep B-IPV</td> <td>DTaP-hepatitis B and poliovirus vaccine</td> <td>added v2.6</td> </tr> <tr> <td>111 <a name="111"> </a> </td> <td>influenza, live, intranasal</td> <td>influenza, levend, intranasaal</td> <td>influenza virus vaccine, live, attenuated, for intranasal use</td> <td>added v2.6</td> </tr> <tr> <td>112 <a name="112"> </a> </td> <td>tetanus toxoid, NOS</td> <td>tetanus toxoïde, niet anders gespecificeerd</td> <td>tetanus toxoid, NOS</td> <td>added v2.6</td> </tr> <tr> <td>113 <a name="113"> </a> </td> <td>Td (adult)</td> <td>DT - difterie en tetanus (volwassene)</td> <td>tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use</td> <td>added v2.6</td> </tr> <tr> <td>114 <a name="114"> </a> </td> <td>meningococcal A,C,Y,W-135 diphtheria conjugate</td> <td>meningokokken A,C,Y,W-135 difterie conjugaat</td> <td>meningococcal polysaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4)</td> <td>added v2.6</td> </tr> <tr> <td>115 <a name="115"> </a> </td> <td>Tdap</td> <td>tetanus toxoïde, verminderde difterie toxoïde, en acellulaire kinkhoest</td> <td>tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine, adsorbed</td> <td>added v2.6</td> </tr> <tr> <td>116 <a name="116"> </a> </td> <td>rotavirus, pentavalent</td> <td>rotavirus, pentavalent</td> <td>rotavirus, live, pentavalent vaccine</td> <td>added v2.6</td> </tr> <tr> <td>117 <a name="117"> </a> </td> <td>VZIG (IND)</td> <td>VZIG (IND)</td> <td>varicella zoster immune globulin (Investigational New Drug)</td> <td>added v2.6</td> </tr> <tr> <td>118 <a name="118"> </a> </td> <td>HPV, bivalent</td> <td>HPV, bivalent</td> <td>human papilloma virus vaccine, bivalent</td> <td>added v2.6</td> </tr> <tr> <td>119 <a name="119"> </a> </td> <td>rotavirus, monovalent</td> <td>rotavirus, monovalent</td> <td>rotavirus, live, monovalent vaccine</td> <td>added v2.6</td> </tr> <tr> <td>12 <a name="12"> </a> </td> <td>diphtheria antitoxin</td> <td>difterie antitoxine</td> <td>diphtheria antitoxin</td> <td>added v2.3</td> </tr> <tr> <td>120 <a name="120"> </a> </td> <td>DTaP-Hib-IPV</td> <td>DaKT-Hib-IPV</td> <td>diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV)</td> <td>added v2.6</td> </tr> <tr> <td>121 <a name="121"> </a> </td> <td>zoster</td> <td>gordelroos</td> <td>zoster vaccine, live</td> <td>added v2.6</td> </tr> <tr> <td>122 <a name="122"> </a> </td> <td>rotavirus, NOS1</td> <td>rotavirus, niet anders gespecificeerd1</td> <td>rotavirus vaccine, NOS</td> <td>added v2.6</td> </tr> <tr> <td>13 <a name="13"> </a> </td> <td>TIG</td> <td>TIG</td> <td>tetanus immune globulin</td> <td>added v2.3</td> </tr> <tr> <td>14 <a name="14"> </a> </td> <td>IG, NOS</td> <td>IG, niet anders gespecificeerd</td> <td>immune globulin, NOS</td> <td>added v2.3</td> </tr> <tr> <td>15 <a name="15"> </a> </td> <td>influenza, split (incl. purified surface antigen)</td> <td>influenza, gesplitst (incl. gezuiverd oppervlakte antigen)</td> <td>influenza virus vaccine, split virus (incl. purified surface antigen)</td> <td>added v2.3</td> </tr> <tr> <td>16 <a name="16"> </a> </td> <td>influenza, whole</td> <td>influenza, geheel</td> <td>influenza virus vaccine, whole virus</td> <td>added v2.3</td> </tr> <tr> <td>17 <a name="17"> </a> </td> <td>Hib, NOS</td> <td>Hib, niet anders gespecificeerd</td> <td>Haemophilus influenzae type b vaccine, conjugate NOS</td> <td>added v2.3</td> </tr> <tr> <td>18 <a name="18"> </a> </td> <td>rabies, intramuscular injection</td> <td>hondsdolheid, intramusculaire injectie</td> <td>rabies vaccine, for intramuscular injection</td> <td>added v2.3</td> </tr> <tr> <td>19 <a name="19"> </a> </td> <td>BCG</td> <td>BCG</td> <td>Bacillus Calmette-Guerin vaccine</td> <td>added v2.3</td> </tr> <tr> <td>20 <a name="20"> </a> </td> <td>DTaP</td> <td>DaKT</td> <td>diphtheria, tetanus toxoids and acellular pertussis vaccine</td> <td>added v2.3</td> </tr> <tr> <td>21 <a name="21"> </a> </td> <td>varicella</td> <td>varicella</td> <td>varicella virus vaccine</td> <td>added v2.3</td> </tr> <tr> <td>22 <a name="22"> </a> </td> <td>DTP-Hib</td> <td>DKT-Hib</td> <td>DTP-Haemophilus influenzae type b conjugate vaccine</td> <td>added v2.3</td> </tr> <tr> <td>23 <a name="23"> </a> </td> <td>plague</td> <td>pest</td> <td>plague vaccine</td> <td>added v2.3</td> </tr> <tr> <td>24 <a name="24"> </a> </td> <td>anthrax</td> <td>miltvuur</td> <td>anthrax vaccine</td> <td>added v2.3</td> </tr> <tr> <td>25 <a name="25"> </a> </td> <td>typhoid, oral</td> <td>tyfus, oral</td> <td>typhoid vaccine, live, oral</td> <td>added v2.3</td> </tr> <tr> <td>26 <a name="26"> </a> </td> <td>cholera</td> <td>cholera</td> <td>cholera vaccine</td> <td>added v2.3</td> </tr> <tr> <td>27 <a name="27"> </a> </td> <td>botulinum antitoxin</td> <td>botulisme antitoxine</td> <td>botulinum antitoxin</td> <td>added v2.3</td> </tr> <tr> <td>28 <a name="28"> </a> </td> <td>DT (pediatric)</td> <td>DT - difterie-tetanus (pediatrie)</td> <td>diphtheria and tetanus toxoids, adsorbed for pediatric use</td> <td>added v2.3</td> </tr> <tr> <td>29 <a name="29"> </a> </td> <td>CMVIG</td> <td>CMVIG</td> <td>cytomegalovirus immune globulin, intravenous</td> <td>added v2.3</td> </tr> <tr> <td>30 <a name="30"> </a> </td> <td>HBIG</td> <td>HBIG</td> <td>hepatitis B immune globulin</td> <td>added v2.3</td> </tr> <tr> <td>31 <a name="31"> </a> </td> <td>Hep A, pediatric, NOS</td> <td>Hep A, pediatrie, niet anders gespecificeerd</td> <td>hepatitis A vaccine, pediatric dosage, NOS</td> <td>added v2.3</td> </tr> <tr> <td>32 <a name="32"> </a> </td> <td>meningococcal</td> <td>meningokokken</td> <td>meningococcal polysaccharide vaccine (MPSV4)</td> <td>added v2.3</td> </tr> <tr> <td>33 <a name="33"> </a> </td> <td>pneumococcal</td> <td>pneumokokken</td> <td>pneumococcal polysaccharide vaccine</td> <td>added v2.3</td> </tr> <tr> <td>34 <a name="34"> </a> </td> <td>RIG</td> <td>hondsdolheid immunoglobuline</td> <td>rabies immune globulin</td> <td>added v2.3</td> </tr> <tr> <td>35 <a name="35"> </a> </td> <td>tetanus toxoid</td> <td>tetanus toxoïde</td> <td>tetanus toxoid, adsorbed</td> <td>added v2.3</td> </tr> <tr> <td>36 <a name="36"> </a> </td> <td>VZIG</td> <td>VZIG</td> <td>varicella zoster immune globulin</td> <td>added v2.3</td> </tr> <tr> <td>37 <a name="37"> </a> </td> <td>yellow fever</td> <td>gele koorts</td> <td>yellow fever vaccine</td> <td>added v2.3</td> </tr> <tr> <td>38 <a name="38"> </a> </td> <td>rubella/mumps</td> <td>rodehond/bof</td> <td>rubella and mumps virus vaccine</td> <td>added v2.3</td> </tr> <tr> <td>39 <a name="39"> </a> </td> <td>Japanese encephalitis</td> <td>Japanse encefalitis</td> <td>Japanese encephalitis vaccine</td> <td>added v2.3</td> </tr> <tr> <td>40 <a name="40"> </a> </td> <td>rabies, intradermal injection</td> <td>hondsdolheid, intradermale injectie</td> <td>rabies vaccine, for intradermal injection</td> <td>added v2.3</td> </tr> <tr> <td>41 <a name="41"> </a> </td> <td>typhoid, parenteral</td> <td>tyfus, parenteraal</td> <td>typhoid vaccine, parenteral, other than acetone-killed, dried</td> <td>added v2.3</td> </tr> <tr> <td>42 <a name="42"> </a> </td> <td>Hep B, adolescent/high risk infant2</td> <td>Hep B, adolescent/hoogrisico zuigeling2</td> <td>hepatitis B vaccine, adolescent/high risk infant dosage</td> <td>added v2.3</td> </tr> <tr> <td>43 <a name="43"> </a> </td> <td>Hep B, adult4</td> <td>Hep B, volwassen4</td> <td>hepatitis B vaccine, adult dosage</td> <td>added v2.3</td> </tr> <tr> <td>44 <a name="44"> </a> </td> <td>Hep B, dialysis</td> <td>Hep B, dialyse</td> <td>hepatitis B vaccine, dialysis patient dosage</td> <td>added v2.3</td> </tr> <tr> <td>45 <a name="45"> </a> </td> <td>Hep B, NOS</td> <td>Hep B, niet anders gespecificeerd</td> <td>hepatitis B vaccine, NOS</td> <td>added v2.3</td> </tr> <tr> <td>46 <a name="46"> </a> </td> <td>Hib (PRP-D)</td> <td>Hib (PRP-D)</td> <td>Haemophilus influenzae type b vaccine, PRP-D conjugate</td> <td>added v2.3</td> </tr> <tr> <td>47 <a name="47"> </a> </td> <td>Hib (HbOC)</td> <td>Hib (HbOC)</td> <td>Haemophilus influenzae type b vaccine, HbOC conjugate</td> <td>added v2.3</td> </tr> <tr> <td>48 <a name="48"> </a> </td> <td>Hib (PRP-T)</td> <td>Hib (PRP-T)</td> <td>Haemophilus influenzae type b vaccine, PRP-T conjugate</td> <td>added v2.3</td> </tr> <tr> <td>49 <a name="49"> </a> </td> <td>Hib (PRP-OMP)</td> <td>Hib (PRP-OMP)</td> <td>Haemophilus influenzae type b vaccine, PRP-OMP conjugate</td> <td>added v2.3</td> </tr> <tr> <td>50 <a name="50"> </a> </td> <td>DTaP-Hib</td> <td>DaKT-Hib</td> <td>DTaP-Haemophilus influenzae type b conjugate vaccine</td> <td>added v2.3</td> </tr> <tr> <td>51 <a name="51"> </a> </td> <td>Hib-Hep B</td> <td>Hib-Hep B</td> <td>Haemophilus influenzae type b conjugate and Hepatitis B vaccine</td> <td>added v2.3</td> </tr> <tr> <td>52 <a name="52"> </a> </td> <td>Hep A, adult</td> <td>Hep A, volwassene</td> <td>hepatitis A vaccine, adult dosage</td> <td>added v2.3</td> </tr> <tr> <td>53 <a name="53"> </a> </td> <td>typhoid, parenteral, AKD (U.S. military)</td> <td>tyfus, parenteraal, AKD (Amerikaanse leger)</td> <td>typhoid vaccine, parenteral, acetone-killed, dried (U.S. military)</td> <td>added v2.3.1</td> </tr> <tr> <td>54 <a name="54"> </a> </td> <td>adenovirus, type 4</td> <td>adenovirus, type 4</td> <td>adenovirus vaccine, type 4, live, oral</td> <td>added v2.3.1</td> </tr> <tr> <td>55 <a name="55"> </a> </td> <td>adenovirus, type 7</td> <td>adenovirus, type 7</td> <td>adenovirus vaccine, type 7, live, oral</td> <td>added v2.3.1</td> </tr> <tr> <td>56 <a name="56"> </a> </td> <td>dengue fever</td> <td>knokkelkoorts</td> <td>dengue fever vaccine</td> <td>added v2.3.1</td> </tr> <tr> <td>57 <a name="57"> </a> </td> <td>hantavirus</td> <td>hantavirus</td> <td>hantavirus vaccine</td> <td>added v2.3.1</td> </tr> <tr> <td>58 <a name="58"> </a> </td> <td>Hep C</td> <td>Hep C</td> <td>hepatitis C vaccine</td> <td>added v2.3.1</td> </tr> <tr> <td>59 <a name="59"> </a> </td> <td>Hep E</td> <td>Hep E</td> <td>hepatitis E vaccine</td> <td>added v2.3.1</td> </tr> <tr> <td>60 <a name="60"> </a> </td> <td>herpes simplex 2</td> <td>herpes simplex 2</td> <td>herpes simplex virus, type 2 vaccine</td> <td>added v2.3.1</td> </tr> <tr> <td>61 <a name="61"> </a> </td> <td>HIV</td> <td>HIV</td> <td>human immunodeficiency virus vaccine</td> <td>added v2.3.1</td> </tr> <tr> <td>62 <a name="62"> </a> </td> <td>HPV, quadrivalent</td> <td>HPV, quadrivalent</td> <td>human papilloma virus vaccine, quadrivalent</td> <td>added v2.3.1</td> </tr> <tr> <td>63 <a name="63"> </a> </td> <td>Junin virus</td> <td>Junín virus</td> <td>Junin virus vaccine</td> <td>added v2.3.1</td> </tr> <tr> <td>64 <a name="64"> </a> </td> <td>leishmaniasis</td> <td>leishmaniase</td> <td>leishmaniasis vaccine</td> <td>added v2.3.1</td> </tr> <tr> <td>65 <a name="65"> </a> </td> <td>leprosy</td> <td>leprosy</td> <td>leprosy vaccine</td> <td>added v2.3.1</td> </tr> <tr> <td>66 <a name="66"> </a> </td> <td>Lyme disease</td> <td>ziekte van Lyme</td> <td>Lyme disease vaccine</td> <td>added v2.3.1</td> </tr> <tr> <td>67 <a name="67"> </a> </td> <td>malaria</td> <td>malaria</td> <td>malaria vaccine</td> <td>added v2.3.1</td> </tr> <tr> <td>68 <a name="68"> </a> </td> <td>melanoma</td> <td>melanoom</td> <td>melanoma vaccine</td> <td>added v2.3.1</td> </tr> <tr> <td>69 <a name="69"> </a> </td> <td>parainfluenza-3</td> <td>parainfluenza-3</td> <td>parainfluenza-3 virus vaccine</td> <td>added v2.3.1</td> </tr> <tr> <td>70 <a name="70"> </a> </td> <td>Q fever</td> <td>Q-koorts</td> <td>Q fever vaccine</td> <td>added v2.3.1</td> </tr> <tr> <td>71 <a name="71"> </a> </td> <td>RSV-IGIV</td> <td>RSV-IGIV</td> <td>respiratory syncytial virus immune globulin, intravenous</td> <td>added v2.3.1</td> </tr> <tr> <td>72 <a name="72"> </a> </td> <td>rheumatic fever</td> <td>reumatische koorts</td> <td>rheumatic fever vaccine</td> <td>added v2.3.1</td> </tr> <tr> <td>73 <a name="73"> </a> </td> <td>Rift Valley fever</td> <td>Riftdalkoorts</td> <td>Rift Valley fever vaccine</td> <td>added v2.3.1</td> </tr> <tr> <td>74 <a name="74"> </a> </td> <td>rotavirus, tetravalent</td> <td>rotavirus, tetravalent</td> <td>rotavirus, live, tetravalent vaccine</td> <td>added v2.3.1</td> </tr> <tr> <td>75 <a name="75"> </a> </td> <td>vaccinia (smallpox)</td> <td>vaccinia (pokken)</td> <td>vaccinia (smallpox) vaccine</td> <td>added v2.3.1</td> </tr> <tr> <td>76 <a name="76"> </a> </td> <td>Staphylococcus bacterio lysate</td> <td>Staphylococcus bacterio lysate</td> <td>Staphylococcus bacteriophage lysate</td> <td>added v2.3.1</td> </tr> <tr> <td>77 <a name="77"> </a> </td> <td>tick-borne encephalitis</td> <td>frühsommer-meningoenzephalitis vaccin</td> <td>tick-borne encephalitis vaccine</td> <td>added v2.3.1</td> </tr> <tr> <td>78 <a name="78"> </a> </td> <td>tularemia vaccine</td> <td>tularemia vaccin</td> <td>tularemia vaccine</td> <td>added v2.3.1</td> </tr> <tr> <td>79 <a name="79"> </a> </td> <td>vaccinia immune globulin</td> <td>vaccinia immunoglobuline</td> <td>vaccinia immune globulin</td> <td>added v2.3.1</td> </tr> <tr> <td>80 <a name="80"> </a> </td> <td>VEE, live</td> <td>VEE, levend</td> <td>Venezuelan equine encephalitis, live, attenuated</td> <td>added v2.3.1</td> </tr> <tr> <td>81 <a name="81"> </a> </td> <td>VEE, inactivated</td> <td>VEE, inactief</td> <td>Venezuelan equine encephalitis, inactivated</td> <td>added v2.3.1</td> </tr> <tr> <td>82 <a name="82"> </a> </td> <td>adenovirus, NOS1</td> <td>adenovirus, niet anders gespecificeerd1</td> <td>adenovirus vaccine, NOS</td> <td>added v2.3.1</td> </tr> <tr> <td>83 <a name="83"> </a> </td> <td>Hep A, ped/adol, 2 dose</td> <td>Hep A, ped/adol, 2 dosis</td> <td>hepatitis A vaccine, pediatric/adolescent dosage, 2 dose schedule</td> <td>added v2.3.1</td> </tr> <tr> <td>84 <a name="84"> </a> </td> <td>Hep A, ped/adol, 3 dose</td> <td>Hep A, ped/adol, 3 dosis</td> <td>hepatitis A vaccine, pediatric/adolescent dosage, 3 dose schedule</td> <td>added v2.3.1</td> </tr> <tr> <td>85 <a name="85"> </a> </td> <td>Hep A, NOS</td> <td>Hep A, niet anders gespecificeerd</td> <td>hepatitis A vaccine, NOS</td> <td>added v2.3.1</td> </tr> <tr> <td>86 <a name="86"> </a> </td> <td>IG</td> <td>IG</td> <td>immune globulin, intramuscular</td> <td>added v2.3.1</td> </tr> <tr> <td>87 <a name="87"> </a> </td> <td>IGIV</td> <td>IGIV</td> <td>immune globulin, intravenous</td> <td>added v2.3.1</td> </tr> <tr> <td>88 <a name="88"> </a> </td> <td>influenza, NOS</td> <td>influenza, niet anders gespecificeerd</td> <td>influenza virus vaccine, NOS</td> <td>added v2.3.1</td> </tr> <tr> <td>89 <a name="89"> </a> </td> <td>polio, NOS</td> <td>polio, niet anders gespecificeerd</td> <td>poliovirus vaccine, NOS</td> <td>added v2.3.1</td> </tr> <tr> <td>90 <a name="90"> </a> </td> <td>rabies, NOS</td> <td>hondsdolheid, niet anders gespecificeerd</td> <td>rabies vaccine, NOS</td> <td>added v2.3.1</td> </tr> <tr> <td>91 <a name="91"> </a> </td> <td>typhoid, NOS</td> <td>tyfus, niet anders gespecificeerd</td> <td>typhoid vaccine, NOS</td> <td>added v2.3.1</td> </tr> <tr> <td>92 <a name="92"> </a> </td> <td>VEE, NOS</td> <td>VEE, niet anders gespecificeerd</td> <td>Venezuelan equine encephalitis vaccine, NOS</td> <td>added v2.3.1</td> </tr> <tr> <td>93 <a name="93"> </a> </td> <td>RSV-MAb</td> <td>RSV-MAb</td> <td>respiratory syncytial virus monoclonal antibody (palivizumab), intramuscular</td> <td>added v2.4</td> </tr> <tr> <td>94 <a name="94"> </a> </td> <td>MMRV</td> <td>BMRV - mazelen, bof, rodehond en varicella</td> <td>measles, mumps, rubella, and varicella virus vaccine</td> <td>added v2.4</td> </tr> <tr> <td>95 <a name="95"> </a> </td> <td>TST-OT tine test</td> <td>TST-OT tine test</td> <td>tuberculin skin test; old tuberculin, multipuncture device</td> <td>added v2.4</td> </tr> <tr> <td>96 <a name="96"> </a> </td> <td>TST-PPD intradermal</td> <td>TST-PPD intradermal</td> <td>tuberculin skin test; purified protein derivative solution, intradermal</td> <td>added v2.4</td> </tr> <tr> <td>97 <a name="97"> </a> </td> <td>TST-PPD tine test</td> <td>TST-PPD tine test</td> <td>tuberculin skin test; purified protein derivative, multipuncture device</td> <td>added v2.4</td> </tr> <tr> <td>98 <a name="98"> </a> </td> <td>TST, NOS</td> <td>TST, niet anders gespecificeerd</td> <td>tuberculin skin test; NOS</td> <td>added v2.4</td> </tr> <tr> <td>99 <a name="99"> </a> </td> <td>RESERVED - do not use3</td> <td>GERESERVEERD - niet gebruiken3</td> <td>RESERVED - do not use</td> <td>added v2.4</td> </tr> <tr> <td>998 <a name="998"> </a> </td> <td>no vaccine administered5</td> <td>geen vaccin toegediend5</td> <td>no vaccine administered</td> <td>added v2.5</td> </tr> <tr> <td>999 <a name="999"> </a> </td> <td>unknown</td> <td>onbekend</td> <td>unknown vaccine or immune globulin</td> <td>added v2.4</td> </tr> </table> </div> </text> <url value="http://hl7.org/fhir/ValueSet/v2-0292"/> <version value="2.8.2"/> <name value="v2 Vaccines Administered (code = CVX) (parenteral, un"/> <status value="active"/> <experimental value="true"/> <publisher value="HL7, Inc"/> <contact> <telecom> <system value="other"/> <value value="http://hl7.org"/> </telecom> </contact> <description value="FHIR Value set/code system definition for HL7 v2 table 0292 ( Vaccines Administered (code = CVX) (parenteral, un)"/> <codeSystem> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-oid"> <valueUri value="urn:oid:2.16.840.1.133883.18.182"/> </extension> <system value="http://hl7.org/fhir/v2/0292"/> <caseSensitive value="false"/> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="diphtheria, tetanus toxoids and pertussis vaccine"/> </extension> <code value="01"/> <display value="DTP"/> <designation> <language value="nl"/> <value value="DKT - difterie-kinkhoest-tetanus"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="poliovirus vaccine, live, oral"/> </extension> <code value="02"/> <display value="OPV"/> <designation> <language value="nl"/> <value value="OPV"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="measles, mumps and rubella virus vaccine"/> </extension> <code value="03"/> <display value="MMR"/> <designation> <language value="nl"/> <value value="BMR - mazelen, bof, rodehond"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="measles and rubella virus vaccine"/> </extension> <code value="04"/> <display value="M/R"/> <designation> <language value="nl"/> <value value="M/R"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="measles virus vaccine"/> </extension> <code value="05"/> <display value="measles"/> <designation> <language value="nl"/> <value value="mazelen"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="rubella virus vaccine"/> </extension> <code value="06"/> <display value="rubella"/> <designation> <language value="nl"/> <value value="rodehond"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="mumps virus vaccine"/> </extension> <code value="07"/> <display value="mumps"/> <designation> <language value="nl"/> <value value="bof"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="hepatitis B vaccine, pediatric or pediatric/adolescent dosage"/> </extension> <code value="08"/> <display value="Hep B, adolescent or pediatric"/> <designation> <language value="nl"/> <value value="Hep B, adolescent of pediatrie"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="tetanus and diphtheria toxoids, adsorbed for adult use"/> </extension> <code value="09"/> <display value="Td (adult)"/> <designation> <language value="nl"/> <value value="DT - difterie en tetanus (volwassene)"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="poliovirus vaccine, inactivated"/> </extension> <code value="10"/> <display value="IPV"/> <designation> <language value="nl"/> <value value="IPV"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="pneumococcal conjugate vaccine, polyvalent"/> </extension> <code value="100"/> <display value="pneumococcal conjugate"/> <designation> <language value="nl"/> <value value="pneumokokken conjugaat"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="typhoid Vi capsular polysaccharide vaccine"/> </extension> <code value="101"/> <display value="typhoid, ViCPs"/> <designation> <language value="nl"/> <value value="tyfus, ViCPs"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="DTP- Haemophilus influenzae type b conjugate and hepatitis b vaccine"/> </extension> <code value="102"/> <display value="DTP-Hib-Hep B"/> <designation> <language value="nl"/> <value value="DKT-Hib-Hep B"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="meningococcal C conjugate vaccine"/> </extension> <code value="103"/> <display value="meningococcal C conjugate"/> <designation> <language value="nl"/> <value value="meningokokken C conjugaat"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="hepatitis A and hepatitis B vaccine"/> </extension> <code value="104"/> <display value="Hep A-Hep B"/> <designation> <language value="nl"/> <value value="Hep A-Hep B"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="vaccinia (smallpox) vaccine, diluted"/> </extension> <code value="105"/> <display value="vaccinia (smallpox) diluted"/> <designation> <language value="nl"/> <value value="vaccinia (pokken) verzwakt"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="diphtheria, tetanus toxoids and acellular pertussis vaccine, 5 pertussis antigens"/> </extension> <code value="106"/> <display value="DTaP, 5 pertussis antigens6"/> <designation> <language value="nl"/> <value value="DaKT, 5 kinkhoest antigenen6"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="diphtheria, tetanus toxoids and acellular pertussis vaccine, NOS"/> </extension> <code value="107"/> <display value="DTaP, NOS"/> <designation> <language value="nl"/> <value value="DaKT, niet anders gespecificeerd"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="meningococcal vaccine, NOS"/> </extension> <code value="108"/> <display value="meningococcal, NOS"/> <designation> <language value="nl"/> <value value="meningokokken, niet anders gespecificeerd"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="pneumococcal vaccine, NOS"/> </extension> <code value="109"/> <display value="pneumococcal, NOS"/> <designation> <language value="nl"/> <value value="pneumokokken, niet anders gespecificeerd"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="pertussis vaccine"/> </extension> <code value="11"/> <display value="pertussis"/> <designation> <language value="nl"/> <value value="kinkhoest"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="DTaP-hepatitis B and poliovirus vaccine"/> </extension> <code value="110"/> <display value="DTaP-Hep B-IPV"/> <designation> <language value="nl"/> <value value="DaKT-Hep B-IPV"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="influenza virus vaccine, live, attenuated, for intranasal use"/> </extension> <code value="111"/> <display value="influenza, live, intranasal"/> <designation> <language value="nl"/> <value value="influenza, levend, intranasaal"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="tetanus toxoid, NOS"/> </extension> <code value="112"/> <display value="tetanus toxoid, NOS"/> <designation> <language value="nl"/> <value value="tetanus toxoïde, niet anders gespecificeerd"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use"/> </extension> <code value="113"/> <display value="Td (adult)"/> <designation> <language value="nl"/> <value value="DT - difterie en tetanus (volwassene)"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="meningococcal polysaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4)"/> </extension> <code value="114"/> <display value="meningococcal A,C,Y,W-135 diphtheria conjugate"/> <designation> <language value="nl"/> <value value="meningokokken A,C,Y,W-135 difterie conjugaat"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine, adsorbed"/> </extension> <code value="115"/> <display value="Tdap"/> <designation> <language value="nl"/> <value value="tetanus toxoïde, verminderde difterie toxoïde, en acellulaire kinkhoest"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="rotavirus, live, pentavalent vaccine"/> </extension> <code value="116"/> <display value="rotavirus, pentavalent"/> <designation> <language value="nl"/> <value value="rotavirus, pentavalent"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="varicella zoster immune globulin (Investigational New Drug)"/> </extension> <code value="117"/> <display value="VZIG (IND)"/> <designation> <language value="nl"/> <value value="VZIG (IND)"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="human papilloma virus vaccine, bivalent"/> </extension> <code value="118"/> <display value="HPV, bivalent"/> <designation> <language value="nl"/> <value value="HPV, bivalent"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="rotavirus, live, monovalent vaccine"/> </extension> <code value="119"/> <display value="rotavirus, monovalent"/> <designation> <language value="nl"/> <value value="rotavirus, monovalent"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="diphtheria antitoxin"/> </extension> <code value="12"/> <display value="diphtheria antitoxin"/> <designation> <language value="nl"/> <value value="difterie antitoxine"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV)"/> </extension> <code value="120"/> <display value="DTaP-Hib-IPV"/> <designation> <language value="nl"/> <value value="DaKT-Hib-IPV"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="zoster vaccine, live"/> </extension> <code value="121"/> <display value="zoster"/> <designation> <language value="nl"/> <value value="gordelroos"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="rotavirus vaccine, NOS"/> </extension> <code value="122"/> <display value="rotavirus, NOS1"/> <designation> <language value="nl"/> <value value="rotavirus, niet anders gespecificeerd1"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="tetanus immune globulin"/> </extension> <code value="13"/> <display value="TIG"/> <designation> <language value="nl"/> <value value="TIG"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="immune globulin, NOS"/> </extension> <code value="14"/> <display value="IG, NOS"/> <designation> <language value="nl"/> <value value="IG, niet anders gespecificeerd"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="influenza virus vaccine, split virus (incl. purified surface antigen)"/> </extension> <code value="15"/> <display value="influenza, split (incl. purified surface antigen)"/> <designation> <language value="nl"/> <value value="influenza, gesplitst (incl. gezuiverd oppervlakte antigen)"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="influenza virus vaccine, whole virus"/> </extension> <code value="16"/> <display value="influenza, whole"/> <designation> <language value="nl"/> <value value="influenza, geheel"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="Haemophilus influenzae type b vaccine, conjugate NOS"/> </extension> <code value="17"/> <display value="Hib, NOS"/> <designation> <language value="nl"/> <value value="Hib, niet anders gespecificeerd"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="rabies vaccine, for intramuscular injection"/> </extension> <code value="18"/> <display value="rabies, intramuscular injection"/> <designation> <language value="nl"/> <value value="hondsdolheid, intramusculaire injectie"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="Bacillus Calmette-Guerin vaccine"/> </extension> <code value="19"/> <display value="BCG"/> <designation> <language value="nl"/> <value value="BCG"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="diphtheria, tetanus toxoids and acellular pertussis vaccine"/> </extension> <code value="20"/> <display value="DTaP"/> <designation> <language value="nl"/> <value value="DaKT"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="varicella virus vaccine"/> </extension> <code value="21"/> <display value="varicella"/> <designation> <language value="nl"/> <value value="varicella"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="DTP-Haemophilus influenzae type b conjugate vaccine"/> </extension> <code value="22"/> <display value="DTP-Hib"/> <designation> <language value="nl"/> <value value="DKT-Hib"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="plague vaccine"/> </extension> <code value="23"/> <display value="plague"/> <designation> <language value="nl"/> <value value="pest"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="anthrax vaccine"/> </extension> <code value="24"/> <display value="anthrax"/> <designation> <language value="nl"/> <value value="miltvuur"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="typhoid vaccine, live, oral"/> </extension> <code value="25"/> <display value="typhoid, oral"/> <designation> <language value="nl"/> <value value="tyfus, oral"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="cholera vaccine"/> </extension> <code value="26"/> <display value="cholera"/> <designation> <language value="nl"/> <value value="cholera"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="botulinum antitoxin"/> </extension> <code value="27"/> <display value="botulinum antitoxin"/> <designation> <language value="nl"/> <value value="botulisme antitoxine"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="diphtheria and tetanus toxoids, adsorbed for pediatric use"/> </extension> <code value="28"/> <display value="DT (pediatric)"/> <designation> <language value="nl"/> <value value="DT - difterie-tetanus (pediatrie)"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="cytomegalovirus immune globulin, intravenous"/> </extension> <code value="29"/> <display value="CMVIG"/> <designation> <language value="nl"/> <value value="CMVIG"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="hepatitis B immune globulin"/> </extension> <code value="30"/> <display value="HBIG"/> <designation> <language value="nl"/> <value value="HBIG"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="hepatitis A vaccine, pediatric dosage, NOS"/> </extension> <code value="31"/> <display value="Hep A, pediatric, NOS"/> <designation> <language value="nl"/> <value value="Hep A, pediatrie, niet anders gespecificeerd"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="meningococcal polysaccharide vaccine (MPSV4)"/> </extension> <code value="32"/> <display value="meningococcal"/> <designation> <language value="nl"/> <value value="meningokokken"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="pneumococcal polysaccharide vaccine"/> </extension> <code value="33"/> <display value="pneumococcal"/> <designation> <language value="nl"/> <value value="pneumokokken"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="rabies immune globulin"/> </extension> <code value="34"/> <display value="RIG"/> <designation> <language value="nl"/> <value value="hondsdolheid immunoglobuline"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="tetanus toxoid, adsorbed"/> </extension> <code value="35"/> <display value="tetanus toxoid"/> <designation> <language value="nl"/> <value value="tetanus toxoïde"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="varicella zoster immune globulin"/> </extension> <code value="36"/> <display value="VZIG"/> <designation> <language value="nl"/> <value value="VZIG"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="yellow fever vaccine"/> </extension> <code value="37"/> <display value="yellow fever"/> <designation> <language value="nl"/> <value value="gele koorts"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="rubella and mumps virus vaccine"/> </extension> <code value="38"/> <display value="rubella/mumps"/> <designation> <language value="nl"/> <value value="rodehond/bof"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="Japanese encephalitis vaccine"/> </extension> <code value="39"/> <display value="Japanese encephalitis"/> <designation> <language value="nl"/> <value value="Japanse encefalitis"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="rabies vaccine, for intradermal injection"/> </extension> <code value="40"/> <display value="rabies, intradermal injection"/> <designation> <language value="nl"/> <value value="hondsdolheid, intradermale injectie"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="typhoid vaccine, parenteral, other than acetone-killed, dried"/> </extension> <code value="41"/> <display value="typhoid, parenteral"/> <designation> <language value="nl"/> <value value="tyfus, parenteraal"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="hepatitis B vaccine, adolescent/high risk infant dosage"/> </extension> <code value="42"/> <display value="Hep B, adolescent/high risk infant2"/> <designation> <language value="nl"/> <value value="Hep B, adolescent/hoogrisico zuigeling2"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="hepatitis B vaccine, adult dosage"/> </extension> <code value="43"/> <display value="Hep B, adult4"/> <designation> <language value="nl"/> <value value="Hep B, volwassen4"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="hepatitis B vaccine, dialysis patient dosage"/> </extension> <code value="44"/> <display value="Hep B, dialysis"/> <designation> <language value="nl"/> <value value="Hep B, dialyse"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="hepatitis B vaccine, NOS"/> </extension> <code value="45"/> <display value="Hep B, NOS"/> <designation> <language value="nl"/> <value value="Hep B, niet anders gespecificeerd"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="Haemophilus influenzae type b vaccine, PRP-D conjugate"/> </extension> <code value="46"/> <display value="Hib (PRP-D)"/> <designation> <language value="nl"/> <value value="Hib (PRP-D)"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="Haemophilus influenzae type b vaccine, HbOC conjugate"/> </extension> <code value="47"/> <display value="Hib (HbOC)"/> <designation> <language value="nl"/> <value value="Hib (HbOC)"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="Haemophilus influenzae type b vaccine, PRP-T conjugate"/> </extension> <code value="48"/> <display value="Hib (PRP-T)"/> <designation> <language value="nl"/> <value value="Hib (PRP-T)"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="Haemophilus influenzae type b vaccine, PRP-OMP conjugate"/> </extension> <code value="49"/> <display value="Hib (PRP-OMP)"/> <designation> <language value="nl"/> <value value="Hib (PRP-OMP)"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="DTaP-Haemophilus influenzae type b conjugate vaccine"/> </extension> <code value="50"/> <display value="DTaP-Hib"/> <designation> <language value="nl"/> <value value="DaKT-Hib"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="Haemophilus influenzae type b conjugate and Hepatitis B vaccine"/> </extension> <code value="51"/> <display value="Hib-Hep B"/> <designation> <language value="nl"/> <value value="Hib-Hep B"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="hepatitis A vaccine, adult dosage"/> </extension> <code value="52"/> <display value="Hep A, adult"/> <designation> <language value="nl"/> <value value="Hep A, volwassene"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="typhoid vaccine, parenteral, acetone-killed, dried (U.S. military)"/> </extension> <code value="53"/> <display value="typhoid, parenteral, AKD (U.S. military)"/> <designation> <language value="nl"/> <value value="tyfus, parenteraal, AKD (Amerikaanse leger)"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="adenovirus vaccine, type 4, live, oral"/> </extension> <code value="54"/> <display value="adenovirus, type 4"/> <designation> <language value="nl"/> <value value="adenovirus, type 4"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="adenovirus vaccine, type 7, live, oral"/> </extension> <code value="55"/> <display value="adenovirus, type 7"/> <designation> <language value="nl"/> <value value="adenovirus, type 7"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="dengue fever vaccine"/> </extension> <code value="56"/> <display value="dengue fever"/> <designation> <language value="nl"/> <value value="knokkelkoorts"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="hantavirus vaccine"/> </extension> <code value="57"/> <display value="hantavirus"/> <designation> <language value="nl"/> <value value="hantavirus"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="hepatitis C vaccine"/> </extension> <code value="58"/> <display value="Hep C"/> <designation> <language value="nl"/> <value value="Hep C"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="hepatitis E vaccine"/> </extension> <code value="59"/> <display value="Hep E"/> <designation> <language value="nl"/> <value value="Hep E"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="herpes simplex virus, type 2 vaccine"/> </extension> <code value="60"/> <display value="herpes simplex 2"/> <designation> <language value="nl"/> <value value="herpes simplex 2"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="human immunodeficiency virus vaccine"/> </extension> <code value="61"/> <display value="HIV"/> <designation> <language value="nl"/> <value value="HIV"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="human papilloma virus vaccine, quadrivalent"/> </extension> <code value="62"/> <display value="HPV, quadrivalent"/> <designation> <language value="nl"/> <value value="HPV, quadrivalent"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="Junin virus vaccine"/> </extension> <code value="63"/> <display value="Junin virus"/> <designation> <language value="nl"/> <value value="Junín virus"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="leishmaniasis vaccine"/> </extension> <code value="64"/> <display value="leishmaniasis"/> <designation> <language value="nl"/> <value value="leishmaniase"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="leprosy vaccine"/> </extension> <code value="65"/> <display value="leprosy"/> <designation> <language value="nl"/> <value value="leprosy"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="Lyme disease vaccine"/> </extension> <code value="66"/> <display value="Lyme disease"/> <designation> <language value="nl"/> <value value="ziekte van Lyme"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="malaria vaccine"/> </extension> <code value="67"/> <display value="malaria"/> <designation> <language value="nl"/> <value value="malaria"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="melanoma vaccine"/> </extension> <code value="68"/> <display value="melanoma"/> <designation> <language value="nl"/> <value value="melanoom"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="parainfluenza-3 virus vaccine"/> </extension> <code value="69"/> <display value="parainfluenza-3"/> <designation> <language value="nl"/> <value value="parainfluenza-3"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="Q fever vaccine"/> </extension> <code value="70"/> <display value="Q fever"/> <designation> <language value="nl"/> <value value="Q-koorts"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="respiratory syncytial virus immune globulin, intravenous"/> </extension> <code value="71"/> <display value="RSV-IGIV"/> <designation> <language value="nl"/> <value value="RSV-IGIV"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="rheumatic fever vaccine"/> </extension> <code value="72"/> <display value="rheumatic fever"/> <designation> <language value="nl"/> <value value="reumatische koorts"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="Rift Valley fever vaccine"/> </extension> <code value="73"/> <display value="Rift Valley fever"/> <designation> <language value="nl"/> <value value="Riftdalkoorts"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="rotavirus, live, tetravalent vaccine"/> </extension> <code value="74"/> <display value="rotavirus, tetravalent"/> <designation> <language value="nl"/> <value value="rotavirus, tetravalent"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="vaccinia (smallpox) vaccine"/> </extension> <code value="75"/> <display value="vaccinia (smallpox)"/> <designation> <language value="nl"/> <value value="vaccinia (pokken)"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="Staphylococcus bacteriophage lysate"/> </extension> <code value="76"/> <display value="Staphylococcus bacterio lysate"/> <designation> <language value="nl"/> <value value="Staphylococcus bacterio lysate"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="tick-borne encephalitis vaccine"/> </extension> <code value="77"/> <display value="tick-borne encephalitis"/> <designation> <language value="nl"/> <value value="frühsommer-meningoenzephalitis vaccin"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="tularemia vaccine"/> </extension> <code value="78"/> <display value="tularemia vaccine"/> <designation> <language value="nl"/> <value value="tularemia vaccin"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="vaccinia immune globulin"/> </extension> <code value="79"/> <display value="vaccinia immune globulin"/> <designation> <language value="nl"/> <value value="vaccinia immunoglobuline"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="Venezuelan equine encephalitis, live, attenuated"/> </extension> <code value="80"/> <display value="VEE, live"/> <designation> <language value="nl"/> <value value="VEE, levend"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="Venezuelan equine encephalitis, inactivated"/> </extension> <code value="81"/> <display value="VEE, inactivated"/> <designation> <language value="nl"/> <value value="VEE, inactief"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="adenovirus vaccine, NOS"/> </extension> <code value="82"/> <display value="adenovirus, NOS1"/> <designation> <language value="nl"/> <value value="adenovirus, niet anders gespecificeerd1"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="hepatitis A vaccine, pediatric/adolescent dosage, 2 dose schedule"/> </extension> <code value="83"/> <display value="Hep A, ped/adol, 2 dose"/> <designation> <language value="nl"/> <value value="Hep A, ped/adol, 2 dosis"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="hepatitis A vaccine, pediatric/adolescent dosage, 3 dose schedule"/> </extension> <code value="84"/> <display value="Hep A, ped/adol, 3 dose"/> <designation> <language value="nl"/> <value value="Hep A, ped/adol, 3 dosis"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="hepatitis A vaccine, NOS"/> </extension> <code value="85"/> <display value="Hep A, NOS"/> <designation> <language value="nl"/> <value value="Hep A, niet anders gespecificeerd"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="immune globulin, intramuscular"/> </extension> <code value="86"/> <display value="IG"/> <designation> <language value="nl"/> <value value="IG"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="immune globulin, intravenous"/> </extension> <code value="87"/> <display value="IGIV"/> <designation> <language value="nl"/> <value value="IGIV"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="influenza virus vaccine, NOS"/> </extension> <code value="88"/> <display value="influenza, NOS"/> <designation> <language value="nl"/> <value value="influenza, niet anders gespecificeerd"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="poliovirus vaccine, NOS"/> </extension> <code value="89"/> <display value="polio, NOS"/> <designation> <language value="nl"/> <value value="polio, niet anders gespecificeerd"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="rabies vaccine, NOS"/> </extension> <code value="90"/> <display value="rabies, NOS"/> <designation> <language value="nl"/> <value value="hondsdolheid, niet anders gespecificeerd"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="typhoid vaccine, NOS"/> </extension> <code value="91"/> <display value="typhoid, NOS"/> <designation> <language value="nl"/> <value value="tyfus, niet anders gespecificeerd"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="Venezuelan equine encephalitis vaccine, NOS"/> </extension> <code value="92"/> <display value="VEE, NOS"/> <designation> <language value="nl"/> <value value="VEE, niet anders gespecificeerd"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="respiratory syncytial virus monoclonal antibody (palivizumab), intramuscular"/> </extension> <code value="93"/> <display value="RSV-MAb"/> <designation> <language value="nl"/> <value value="RSV-MAb"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="measles, mumps, rubella, and varicella virus vaccine"/> </extension> <code value="94"/> <display value="MMRV"/> <designation> <language value="nl"/> <value value="BMRV - mazelen, bof, rodehond en varicella"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="tuberculin skin test; old tuberculin, multipuncture device"/> </extension> <code value="95"/> <display value="TST-OT tine test"/> <designation> <language value="nl"/> <value value="TST-OT tine test"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="tuberculin skin test; purified protein derivative solution, intradermal"/> </extension> <code value="96"/> <display value="TST-PPD intradermal"/> <designation> <language value="nl"/> <value value="TST-PPD intradermal"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="tuberculin skin test; purified protein derivative, multipuncture device"/> </extension> <code value="97"/> <display value="TST-PPD tine test"/> <designation> <language value="nl"/> <value value="TST-PPD tine test"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="tuberculin skin test; NOS"/> </extension> <code value="98"/> <display value="TST, NOS"/> <designation> <language value="nl"/> <value value="TST, niet anders gespecificeerd"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="RESERVED - do not use"/> </extension> <code value="99"/> <display value="RESERVED - do not use3"/> <designation> <language value="nl"/> <value value="GERESERVEERD - niet gebruiken3"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="no vaccine administered"/> </extension> <code value="998"/> <display value="no vaccine administered5"/> <designation> <language value="nl"/> <value value="geen vaccin toegediend5"/> </designation> </concept> <concept> <extension url="http://hl7.org/fhir/StructureDefinition/valueset-comments"> <valueString value="unknown vaccine or immune globulin"/> </extension> <code value="999"/> <display value="unknown"/> <designation> <language value="nl"/> <value value="onbekend"/> </designation> </concept> </codeSystem> </ValueSet>
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.
© HL7.org 2011+. FHIR DSTU2 (v1.0.2-7202) generated on Sat, Oct 24, 2015 07:44+1100.
Links: Search |
Version History |
Table of Contents |
Compare to DSTU1 |
|
Propose a change